✦ LIBER ✦

Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)

✍ Scribed by Liao, Hsuan-Chieh; Huang, Yu-Hsiu; Chen, Yann-Jang; Kao, Shu-Min; Lin, Hsiang-Yu; Huang, Chun-Kai; Liu, Hao-Chuan; Hsu, Ting-Rong; Lin, Shuan-Pei; Yang, Chia-Feng; Fann, Cathy S.J.; Chiu, Pao-Chin; Hsieh, Kai-Sheng; Fu, Yun-Ching; Ke, Yu-Yuan; Lin, Ching-Yuang; Tsai, Fuu-Jen; Wang, Chung-Hsing; Chao, Mei-Chyn; Yu, Wen-Chung; Chiang, Chuan-Chi; Niu, Dau-Ming

Book ID: 122107545
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 684 KB
Volume: 426
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cca.2013.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of plasma globotriaosylsphing

Evaluation of plasma globotriaosylsphingosine (LysoGb3) in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4+919G A)

✍ Niu, Dau-Ming; Liao, Hsuan-Chieh; Huang, Yu-Hsiu; Kao, Shu-Min; Li, Shao-Tzu; Hu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Enzyme assay and clinical assessment in

Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A)

✍ Hsiang-Yu Lin; Cheng-Hung Huang; Hsiao-Chi Yu; Kah-Wai Chong; Ju-Hui Hsu; Pi-Cha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 143 KB

Effects of enzyme replacement therapy fo

Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)

✍ Lin, H.-Y.; Liu, H.-C.; Huang, Y.-H.; Liao, H.-C.; Hsu, T.-R.; Shen, C.-I.; Li, 📂 Article 📅 2013 🏛 BMJ 🌐 English ⚖ 393 KB

Age at first cardiac symptoms in Fabry d

Age at first cardiac symptoms in Fabry disease: association with a Chinese hotspot Fabry mutation (IVS4+919G>A), classical mutations, and sex in a Taiwanese population from the Fabry Outcome Survey (FOS)

✍ Niu, Dau-Ming; Larroque, Sylvain; Liu, Hao-Chuan; Hsu, Ting-Rong; Yang, Chia-Fen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB